Literature DB >> 15886527

Cryptotanshinone but not tanshinone IIA inhibits angiogenesisin vitro.

Jong Moon Hur1, Joong Sup Shim, Hye Jin Jung, Ho Jeong Kwon.   

Abstract

In the course of screening of angiogenesis inhibitor from natural products, cryptotanshinone from Salvia miltiorrhiza was isolated as a potent small molecule inhibitor of angiogenesis. Cryptotanshinone inhibits bFGF-induced angiogenesis of BAECs at ten micromolar ranges in vitro without cytotoxicity. Tanshinone IIA, another tanshinone isolated from S. miltiorrhiza, which is structurally very similar to cryptotanshinone except C-15 position of dihydrofuran ring does not inhibit angiogenesis induced by bFGF. These results demonstrate that cryptotanshinone is a new anti-angiogenic agent and double bond at C-15 position of the dihydrofuran ring plays a crucial role in the activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886527     DOI: 10.1038/emm.2005.18

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  25 in total

1.  Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.

Authors:  LianDong Hu; Qianbin Xing; Jian Meng; Chuang Shang
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

2.  Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways.

Authors:  Yan Luo; Wenxing Chen; Hongyu Zhou; Lei Liu; Tao Shen; J Steven Alexander; Shizhong Zheng; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-31

Review 3.  Molecular evidence of cryptotanshinone for treatment and prevention of human cancer.

Authors:  Wenxing Chen; Yin Lu; Guangying Chen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

4.  Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E.

Authors:  Yuqing Ge; Rubin Cheng; Yuhong Zhou; Jianping Shen; Laijun Peng; Xiaofeng Xu; Qun Dai; Pei Liu; Haibing Wang; Xiaoqiong Ma; Jia Jia; Zhe Chen
Journal:  Mol Cell Biochem       Date:  2012-05-22       Impact factor: 3.396

5.  Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.

Authors:  Defeng Xu; Tzu-Hua Lin; Shaoshun Li; Jun Da; Xing-Qiao Wen; Jiang Ding; Chawnshang Chang; Shuyuan Yeh
Journal:  Cancer Lett       Date:  2011-10-10       Impact factor: 8.679

6.  Cryptotanshinone reverses reproductive disturbances in rats with dehydroepiandrosterone-induced polycystic ovary syndrome.

Authors:  Yanqiu Xia; Pei Zhao; Hongli Huang; Yuan Xie; Rong Lu; Li Dong
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

7.  Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling.

Authors:  Shanhu Li; Hongtao Wang; Liu Hong; Wei Liu; Fang Huang; Jian Wang; Peng Wang; Xiaoqing Zhang; Jianguang Zhou
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

8.  Inhibitory effect of cryptotanshinone on angiogenesis and Wnt/β-catenin signaling pathway in human umbilical vein endothelial cells.

Authors:  Qian Chen; Qin Zhuang; Wei Mao; Xiao-ming Xu; Li-hui Wang; Hai-bing Wang
Journal:  Chin J Integr Med       Date:  2014-04-16       Impact factor: 1.978

9.  Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Fangyan Zhang; Wenhua Zheng; Rongbiao Pi; Zhengrong Mei; Yingxia Bao; Jie Gao; Wenjie Tang; Shaorui Chen; Peiqing Liu
Journal:  Exp Brain Res       Date:  2008-10-21       Impact factor: 1.972

Review 10.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.